Literature DB >> 30222604

Pathologic Subtypes of Lung Adenocarcinoma Brain Metastasis Is a Strong Predictor of Survival After Resection.

François Casteillo1, Jean-Baptiste Guy2, Pierre Dal-Col1, Georgia Karpathiou1, Benjamin Pommier3, Sophie Bayle-Bleuez4, Pierre Fournel5, François Vassal3, Fabien Forest1.   

Abstract

Primary lung adenocarcinoma is classified according to predominant histopathologic architecture into lepidic, papillary, acinar, solid, and micropapillary subtypes. These subtypes are related to overall survival in primary lung adenocarcinoma. The main goal of our work was to evaluate the prognostic impact of this classification on surgical resection of brain adenocarcinoma metastases in 97 patients with surgically resected brain metastases of lung adenocarcinoma from 2008 to 2017. Histopathologic subtype is associated with overall survival (P=0.0085): 30.1±5.6 months for papillary-predominant pattern, 26.5±6.3 months for acinar-predominant pattern, 13.8±1.4 months for solid pattern, 11.6±10.1 for micropapillary pattern. A "low grade" group comprising acinar and papillary-predominant pattern tumors showed a longer overall survival (28.5±4.1 mo) when compared with high-grade-predominant pattern (solid and micropapillary patterns) (13.7±1.4 mo), P=0.0011. On multivariate analysis, age below 55 years at the time of resection (hazard ratio, 3.56; 95% confidence interval, 1.12-11.31) and groups of architectural patterns (hazard ratio, 4.25; 95% confidence interval, 1.83-9.9) were related to overall survival (P=0.031 and 0.00078, respectively). Predominant architectural pattern evaluated on the surgical specimen of brain metastasis is a major prognostic factor of overall survival in metastatic lung adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30222604     DOI: 10.1097/PAS.0000000000001161

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  5 in total

1.  Clinical significance of tumor necrosis and viability in non-small cell lung cancer.

Authors:  Seok Whan Moon; Jae Jun Kim; Seong Cheol Jeong; Yong Hwan Kim; Jung Wook Han
Journal:  J Thorac Dis       Date:  2022-04       Impact factor: 3.005

2.  Using CT texture analysis to differentiate between peripheral lung cancer and pulmonary inflammatory pseudotumor.

Authors:  Chenlu Liu; Changsheng Ma; Jinghao Duan; Qingtao Qiu; Yanluan Guo; Zhenhua Zhang; Yong Yin
Journal:  BMC Med Imaging       Date:  2020-07-06       Impact factor: 1.930

3.  Anti-CK7/CK20 Immunohistochemistry Did Not Associate with the Metastatic Site in TTF-1-Negative Lung Cancer.

Authors:  Alice Court; David Laville; Sami Dagher; Vincent Grosjean; Pierre Dal-Col; Violaine Yvorel; François Casteillo; Sophie Bayle-Bleuez; Jean-Michel Vergnon; Fabien Forest
Journal:  Diagnostics (Basel)       Date:  2022-06-29

4.  Brain metastasis PD-L1 and CD8 expression is dependent on primary tumor type and its PD-L1 and CD8 status.

Authors:  Florian Camy; Georgia Karpathiou; Jean Marc Dumollard; Nicolas Magne; Jean Luc Perrot; Francois Vassal; Tiphanie Picot; Mousa Mobarki; Fabien Forest; Francois Casteillo; Sirine Hathroubi; Marios Froudarakis; Michel Peoc'h
Journal:  J Immunother Cancer       Date:  2020-08       Impact factor: 13.751

5.  Adenocarcinoma of High-Grade Patterns Associated with Distinct Outcome of First-Line Chemotherapy or EGFR-TKIs in Patients of Relapsed Lung Cancer.

Authors:  Xiaofei Yu; Zhengwei Dong; Wanying Wang; Shiqi Mao; Yingying Pan; Yiwei Liu; Shuo Yang; Bin Chen; Chunyan Wang; Xuefei Li; Chao Zhao; Keyi Jia; Chuchu Shao; Chunyan Wu; Shengxiang Ren; Caicun Zhou
Journal:  Cancer Manag Res       Date:  2021-05-17       Impact factor: 3.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.